Clinical trial
A Phase I/II Study of TRK-950 in Patients With Advanced Solid Tumors
NCT05423262 is registered in ClinicalTrials.gov with Toray Industries, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of TRK-950 in Patients With Advanced Solid Tumors
- Lead sponsor
- Toray Industries, Inc
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- July 6, 2022
- Completion date
- March 31, 2028
- Enrollment
- 49 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
melanoma, solid tumor